BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | -- | 17.06M | 15.15M | 14.00M | 14.47M | 24.38M | |
| R&D | -- | 12.22M | 10.67M | 9.82M | 9.73M | 13.97M | |
| SG&A | -- | 4.84M | 4.47M | 4.18M | 4.74M | 10.41M | |
| Operating Income | -- | -17.06M | -15.15M | -14.00M | -14.47M | -24.38M | |
| EBITDA | -- | -16.74M | -14.84M | -13.70M | -14.19M | -23.13M | |
| Pretax Income | -- | -15.68M | -13.88M | -12.88M | -13.55M | -23.69M | |
| Net Income | -- | -15.68M | -13.88M | -12.88M | -13.55M | -23.69M | |
| EPS Diluted | -- | -0.70 | -0.62 | -0.58 | -0.60 | -1.06 | |
| Diluted Shares | -- | 22.36M | 22.39M | 22.40M | 22.41M | 22.45M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--